Related references
Note: Only part of the references are listed.The Role of Clopidogrel in 2020: A Reappraisal
Giuseppe Patti et al.
CARDIOVASCULAR THERAPEUTICS (2020)
Mortality and adverse events with brand and generic clopidogrel in the US Food and Drug Administration Adverse Event Reporting System
Victor L. Serebruany et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2019)
The non-haemostatic role of platelets in systemic lupus erythematosus
Petrus Linge et al.
NATURE REVIEWS RHEUMATOLOGY (2018)
New Insights on Platelets and Platelet-Derived Microparticles in Systemic Lupus Erythematosus
Marc Scherlinger et al.
CURRENT RHEUMATOLOGY REPORTS (2017)
Platelet CD154 Potentiates Interferon-α Secretion by Plasmacytoid Dendritic Cells in Systemic Lupus Erythematosus
Pierre Duffau et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Effects of clopidogrel on soluble CD40 ligand and on high-sensitivity C-reactive protein in patients with stable coronary artery disease -: art. no. e1
RR Azar et al.
AMERICAN HEART JOURNAL (2006)
Share Paper
